Pathways to a cancer-free future

A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia

Louiza S. Velentzis, Megan A. Smith, Kate T. Simms, Jie Bin Lew, Michaela Hall, Suzanne Hughes, Susan Yuill, James Killen, Adam Keane, Katherine Butler, Jessica Darlington-Brown, Harriet Hui, Julia M.L. Brotherton, Rachel Skinner, Alison Brand, Lara Roeske, Stella Heley, Jonathan Carter, Deborah Bateson, Ian Frazer & 9 others Suzanne M. Garland, Rebecca Guy, Ian Hammond, Paul Grogan, Marc Arbyn, Philip E. Castle, Marion Saville, Bruce K. Armstrong, Karen Canfell

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Australia's HPV vaccination and HPV-based cervical screening programs are changing the landscape in cervical cancer prevention. We aim to identify areas which can make the biggest further impact on cervical cancer burden. This protocol describes the first stage of a program of work called Pathways-Cervix that aims to generate evidence from modelled evaluations of interventions across the cervical cancer spectrum. Methods: Based on evidence from literature reviews and guidance from a multi-disciplinary Scientific Advisory Committee (SAC), the most relevant evaluations for prevention, diagnosis and treatment were identified. Results: Priority evaluations agreed by the SAC included: increasing/decreasing and retaining vaccination uptake at the current level; vaccinating older women; increasing screening participation; methods for triaging HPV-positive women; improving the diagnosis of cervical intraepithelial neoplasia (CIN) and cancer; treating cervical abnormalities and cancer; and vaccinating women treated for CIN2/3 to prevent recurrence. Evaluations will be performed using a simulation model, Policy1-Cervix previously used to perform policy evaluations in Australia. Exploratory modelling of interventions using idealised scenarios will initially be conducted in single birth cohorts. If these have a significant impact on findings then evaluations with more realistic assumptions will be conducted. Promising strategies will be investigated further by multi-cohort simulations predicting health outcomes, resource use and cost outcomes. Conclusions: Pathways-Cervix will assess the relative benefits of strategies and treatment options in a systematic and health economic framework, producing a list of ‘best buys’ for future decision-making in cervical cancer control.

Original languageEnglish (US)
Pages (from-to)465-471
Number of pages7
JournalGynecologic Oncology
Volume152
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Uterine Cervical Neoplasms
Cervix Uteri
Neoplasms
Advisory Committees
Vaccination
Cervical Intraepithelial Neoplasia
Health Resources
Decision Making
Economics
Parturition
Costs and Cost Analysis
Recurrence
Health
Therapeutics

Keywords

  • Cervical cancer
  • Cervical cancer prevention
  • Evaluation
  • Health economics
  • Modelling
  • Simulation

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Pathways to a cancer-free future : A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. / Velentzis, Louiza S.; Smith, Megan A.; Simms, Kate T.; Lew, Jie Bin; Hall, Michaela; Hughes, Suzanne; Yuill, Susan; Killen, James; Keane, Adam; Butler, Katherine; Darlington-Brown, Jessica; Hui, Harriet; Brotherton, Julia M.L.; Skinner, Rachel; Brand, Alison; Roeske, Lara; Heley, Stella; Carter, Jonathan; Bateson, Deborah; Frazer, Ian; Garland, Suzanne M.; Guy, Rebecca; Hammond, Ian; Grogan, Paul; Arbyn, Marc; Castle, Philip E.; Saville, Marion; Armstrong, Bruce K.; Canfell, Karen.

In: Gynecologic Oncology, Vol. 152, No. 3, 01.03.2019, p. 465-471.

Research output: Contribution to journalArticle

Velentzis, LS, Smith, MA, Simms, KT, Lew, JB, Hall, M, Hughes, S, Yuill, S, Killen, J, Keane, A, Butler, K, Darlington-Brown, J, Hui, H, Brotherton, JML, Skinner, R, Brand, A, Roeske, L, Heley, S, Carter, J, Bateson, D, Frazer, I, Garland, SM, Guy, R, Hammond, I, Grogan, P, Arbyn, M, Castle, PE, Saville, M, Armstrong, BK & Canfell, K 2019, 'Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia', Gynecologic Oncology, vol. 152, no. 3, pp. 465-471. https://doi.org/10.1016/j.ygyno.2018.12.019
Velentzis, Louiza S. ; Smith, Megan A. ; Simms, Kate T. ; Lew, Jie Bin ; Hall, Michaela ; Hughes, Suzanne ; Yuill, Susan ; Killen, James ; Keane, Adam ; Butler, Katherine ; Darlington-Brown, Jessica ; Hui, Harriet ; Brotherton, Julia M.L. ; Skinner, Rachel ; Brand, Alison ; Roeske, Lara ; Heley, Stella ; Carter, Jonathan ; Bateson, Deborah ; Frazer, Ian ; Garland, Suzanne M. ; Guy, Rebecca ; Hammond, Ian ; Grogan, Paul ; Arbyn, Marc ; Castle, Philip E. ; Saville, Marion ; Armstrong, Bruce K. ; Canfell, Karen. / Pathways to a cancer-free future : A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. In: Gynecologic Oncology. 2019 ; Vol. 152, No. 3. pp. 465-471.
@article{fc9d51c5378e47b483cd25da875fa5f7,
title = "Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia",
abstract = "Objective: Australia's HPV vaccination and HPV-based cervical screening programs are changing the landscape in cervical cancer prevention. We aim to identify areas which can make the biggest further impact on cervical cancer burden. This protocol describes the first stage of a program of work called Pathways-Cervix that aims to generate evidence from modelled evaluations of interventions across the cervical cancer spectrum. Methods: Based on evidence from literature reviews and guidance from a multi-disciplinary Scientific Advisory Committee (SAC), the most relevant evaluations for prevention, diagnosis and treatment were identified. Results: Priority evaluations agreed by the SAC included: increasing/decreasing and retaining vaccination uptake at the current level; vaccinating older women; increasing screening participation; methods for triaging HPV-positive women; improving the diagnosis of cervical intraepithelial neoplasia (CIN) and cancer; treating cervical abnormalities and cancer; and vaccinating women treated for CIN2/3 to prevent recurrence. Evaluations will be performed using a simulation model, Policy1-Cervix previously used to perform policy evaluations in Australia. Exploratory modelling of interventions using idealised scenarios will initially be conducted in single birth cohorts. If these have a significant impact on findings then evaluations with more realistic assumptions will be conducted. Promising strategies will be investigated further by multi-cohort simulations predicting health outcomes, resource use and cost outcomes. Conclusions: Pathways-Cervix will assess the relative benefits of strategies and treatment options in a systematic and health economic framework, producing a list of ‘best buys’ for future decision-making in cervical cancer control.",
keywords = "Cervical cancer, Cervical cancer prevention, Evaluation, Health economics, Modelling, Simulation",
author = "Velentzis, {Louiza S.} and Smith, {Megan A.} and Simms, {Kate T.} and Lew, {Jie Bin} and Michaela Hall and Suzanne Hughes and Susan Yuill and James Killen and Adam Keane and Katherine Butler and Jessica Darlington-Brown and Harriet Hui and Brotherton, {Julia M.L.} and Rachel Skinner and Alison Brand and Lara Roeske and Stella Heley and Jonathan Carter and Deborah Bateson and Ian Frazer and Garland, {Suzanne M.} and Rebecca Guy and Ian Hammond and Paul Grogan and Marc Arbyn and Castle, {Philip E.} and Marion Saville and Armstrong, {Bruce K.} and Karen Canfell",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.ygyno.2018.12.019",
language = "English (US)",
volume = "152",
pages = "465--471",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Pathways to a cancer-free future

T2 - A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia

AU - Velentzis, Louiza S.

AU - Smith, Megan A.

AU - Simms, Kate T.

AU - Lew, Jie Bin

AU - Hall, Michaela

AU - Hughes, Suzanne

AU - Yuill, Susan

AU - Killen, James

AU - Keane, Adam

AU - Butler, Katherine

AU - Darlington-Brown, Jessica

AU - Hui, Harriet

AU - Brotherton, Julia M.L.

AU - Skinner, Rachel

AU - Brand, Alison

AU - Roeske, Lara

AU - Heley, Stella

AU - Carter, Jonathan

AU - Bateson, Deborah

AU - Frazer, Ian

AU - Garland, Suzanne M.

AU - Guy, Rebecca

AU - Hammond, Ian

AU - Grogan, Paul

AU - Arbyn, Marc

AU - Castle, Philip E.

AU - Saville, Marion

AU - Armstrong, Bruce K.

AU - Canfell, Karen

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Objective: Australia's HPV vaccination and HPV-based cervical screening programs are changing the landscape in cervical cancer prevention. We aim to identify areas which can make the biggest further impact on cervical cancer burden. This protocol describes the first stage of a program of work called Pathways-Cervix that aims to generate evidence from modelled evaluations of interventions across the cervical cancer spectrum. Methods: Based on evidence from literature reviews and guidance from a multi-disciplinary Scientific Advisory Committee (SAC), the most relevant evaluations for prevention, diagnosis and treatment were identified. Results: Priority evaluations agreed by the SAC included: increasing/decreasing and retaining vaccination uptake at the current level; vaccinating older women; increasing screening participation; methods for triaging HPV-positive women; improving the diagnosis of cervical intraepithelial neoplasia (CIN) and cancer; treating cervical abnormalities and cancer; and vaccinating women treated for CIN2/3 to prevent recurrence. Evaluations will be performed using a simulation model, Policy1-Cervix previously used to perform policy evaluations in Australia. Exploratory modelling of interventions using idealised scenarios will initially be conducted in single birth cohorts. If these have a significant impact on findings then evaluations with more realistic assumptions will be conducted. Promising strategies will be investigated further by multi-cohort simulations predicting health outcomes, resource use and cost outcomes. Conclusions: Pathways-Cervix will assess the relative benefits of strategies and treatment options in a systematic and health economic framework, producing a list of ‘best buys’ for future decision-making in cervical cancer control.

AB - Objective: Australia's HPV vaccination and HPV-based cervical screening programs are changing the landscape in cervical cancer prevention. We aim to identify areas which can make the biggest further impact on cervical cancer burden. This protocol describes the first stage of a program of work called Pathways-Cervix that aims to generate evidence from modelled evaluations of interventions across the cervical cancer spectrum. Methods: Based on evidence from literature reviews and guidance from a multi-disciplinary Scientific Advisory Committee (SAC), the most relevant evaluations for prevention, diagnosis and treatment were identified. Results: Priority evaluations agreed by the SAC included: increasing/decreasing and retaining vaccination uptake at the current level; vaccinating older women; increasing screening participation; methods for triaging HPV-positive women; improving the diagnosis of cervical intraepithelial neoplasia (CIN) and cancer; treating cervical abnormalities and cancer; and vaccinating women treated for CIN2/3 to prevent recurrence. Evaluations will be performed using a simulation model, Policy1-Cervix previously used to perform policy evaluations in Australia. Exploratory modelling of interventions using idealised scenarios will initially be conducted in single birth cohorts. If these have a significant impact on findings then evaluations with more realistic assumptions will be conducted. Promising strategies will be investigated further by multi-cohort simulations predicting health outcomes, resource use and cost outcomes. Conclusions: Pathways-Cervix will assess the relative benefits of strategies and treatment options in a systematic and health economic framework, producing a list of ‘best buys’ for future decision-making in cervical cancer control.

KW - Cervical cancer

KW - Cervical cancer prevention

KW - Evaluation

KW - Health economics

KW - Modelling

KW - Simulation

UR - http://www.scopus.com/inward/record.url?scp=85060516610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060516610&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2018.12.019

DO - 10.1016/j.ygyno.2018.12.019

M3 - Article

VL - 152

SP - 465

EP - 471

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -